Showing 1 - 5 results of 5 for search 'Suzanne Barker‐Collo', query time: 0.01s Refine Results
  1. 1
    Experience of Acceptance and Commitment Therapy for those with mild traumatic brain injury (ACTion mTBI): A qualitative descriptive study.

    Experience of Acceptance and Commitment Therapy for those with mild traumatic brain injury (ACTion mTBI): A qualitative descriptive study. by Josh W Faulkner, Jason Chua, Amabelle Voice-Powell, Deborah L Snell, Maree Roche, John Moffat, Suzanne Barker-Collo, Alice Theadom

    Published 2025-01-01
    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    Fatigue After Stroke Educational Recovery Program: A Prospective, Phase III, Randomized Controlled Trial

    Fatigue After Stroke Educational Recovery Program: A Prospective, Phase III, Randomized Controlled Trial by Kelly Jones, Rita Krishnamurthi, Suzanne Barker‐Collo, Sulekha De Silva, Nathan Henry, Irene Zeng, Anja Vorster, Braden Te Ao, Geoff Green, Yogini Ratnasabapathy, Valery Feigin

    Published 2025-01-01
    Get full text
    Article
    Save to List
    Saved in:
  3. 3
    A double-blind, placebo-controlled, randomized, multi-centre, phase III study of MLC901 (NeuroAiDTMII) for the treatment of cognitive impairment after mild traumatic brain injury.

    A double-blind, placebo-controlled, randomized, multi-centre, phase III study of MLC901 (NeuroAiDTMII) for the treatment of cognitive impairment after mild traumatic brain injury. by Pavel I Pilipenko, Anna A Ivanova, Yulia V Kotsiubinskaya, Vera N Grigoryeva, Alexey Y Khrulev, Anatoly V Skorokhodov, Maxim M Gavrik, Nona N Mkrtchan, Marek Majdan, Peter Valkovic, Daria Rabarova, Suzanne Barker-Collo, Kelly Jones, Valery L Feigin

    Published 2025-01-01
    Get full text
    Article
    Save to List
    Saved in:
  4. 4
    A double-blind, placebo-controlled, randomized, multi-centre, phase III study of MLC901 (NeuroAiDTMII) for the treatment of cognitive impairment after mild traumatic brain injury

    A double-blind, placebo-controlled, randomized, multi-centre, phase III study of MLC901 (NeuroAiDTMII) for the treatment of cognitive impairment after mild traumatic brain injury by Pavel I. Pilipenko, Anna A. Ivanova, Yulia V. Kotsiubinskaya, Vera N. Grigoryeva, Alexey Y. Khrulev, Anatoly V. Skorokhodov, Maxim M. Gavrik, Nona N. Mkrtchan, Marek Majdan, Peter Valkovic, Daria Rabarova, Suzanne Barker-Collo, Kelly Jones, Valery L. Feigin

    Published 2025-01-01
    Get full text
    Article
    Save to List
    Saved in:
  5. 5
    Trends in stroke incidence, death, and disability outcomes in a multi-ethnic population: Auckland regional community stroke studies (1981–2022)Research in context

    Trends in stroke incidence, death, and disability outcomes in a multi-ethnic population: Auckland regional community stroke studies (1981–2022)Research in context by Valery L. Feigin, Rita Krishnamurthi, Balakrishnan Nair, Ilari Rautalin, Varsha Parag, Craig S. Anderson, Bruce Arroll, P. Alan Barber, Suzanne Barker-Collo, Derrick Bennett, Paul Brown, Dominque A. Cadilhac, Jeroen Douwes, Daniel Exeter, Anna Ranta, Yogini Ratnasabapathy, Andrew Swain, El-Shadan Tautolo, Braden Te Ao, Amanda Thrift, Bronwyn Tunnage

    Published 2025-03-01
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: